Perimeter Medical Imaging AI (PYNKF) Stock Price & Analysis
PYNKF Stock Chart & Stats
- Day’s Range
- $0.10 - $0.11
- 52-Week Range
- $0.10 - $0.53
- Previous Close
- $0.12
- Volume
- N/A
- Average Volume (3M)
- 104.80K
- Market Cap
- $15.76M
- Enterprise Value
- $35.07M
- Total Cash (Recent Filing)
- $6.43M
- Total Debt (Recent Filing)
- $4.01M
- Price to Earnings (P/E)
- ―
- Beta
- 0.76
- Next Earnings
- Nov 17, 2026 (Est.)
- EPS Estimate
- -0.03
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Recurring Revenue Growth
The shift toward fully recurring revenue from consumables, leases, maintenance, and warranty programs can improve visibility as the installed base expands. Sequential growth also indicates increasing utilization and provides a foundation for scaling revenue beyond one-time system placements.
FDA Approval And Commercial Traction
FDA PMA approval removes an important regulatory barrier for the next-generation AI-enabled system and supports broader commercialization. Early installed B-Series systems provide real-world operating evidence, reference sites, and a platform for converting legacy users and winning new hospitals.
Improving Cost Discipline
Lower operating expenses and reduced cash use show that management is actively controlling the cost base while pursuing commercialization. If this discipline persists during the sales ramp, it can extend financial flexibility and reduce the funding required to support future growth.
Bears Say
Small Commercial Scale
The company remains at an early commercialization stage, with a modest revenue base and limited deployment of its newest system. This scale leaves results sensitive to the timing of individual hospital conversions and means fixed costs remain high relative to current revenue.
Persistent Losses And Cash Burn
Deep losses and substantial negative cash flow indicate that commercialization has not yet produced self-funding operations. Even with year-over-year improvement, continued investment and a stated cash runway of roughly 12 months leave execution dependent on achieving growth or obtaining additional funding.
Hospital AI/IT Review Delays
Lengthy and inconsistent hospital review processes can delay adoption of the AI-enabled B-Series even when clinical interest exists. Slower approvals may defer revenue recognition, make the sales pipeline less predictable, and prolong the period before the company reaches meaningful commercial scale.
Perimeter Medical Imaging AI News
PYNKF FAQ
What was Perimeter Medical Imaging AI’s price range in the past 12 months?
What is Perimeter Medical Imaging AI’s market cap?
When is Perimeter Medical Imaging AI’s upcoming earnings report date?
How were Perimeter Medical Imaging AI’s earnings last quarter?
Is Perimeter Medical Imaging AI overvalued?
Does Perimeter Medical Imaging AI pay dividends?
What is Perimeter Medical Imaging AI’s EPS estimate?
How many shares outstanding does Perimeter Medical Imaging AI have?
What happened to Perimeter Medical Imaging AI’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Perimeter Medical Imaging AI?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Perimeter Medical Imaging AI
Perimeter Medical Imaging AI, Inc. is a medical technology firm focused on developing and marketing advanced imaging solutions. These innovations empower surgeons, radiologists, and pathologists to meticulously examine microscopic tissue structures directly within a clinical setting. A cornerstone offering is their optical coherence tomography (OCT) imaging system, which delivers detailed cross-sectional views of tissues to a depth of 2 millimeters, comprising the S-series OCT, B-series OCT, and an associated imaging console. Complementing this, ImgAssist, an artificial intelligence platform, streamlines image analysis. When integrated with Perimeter's OCT technology, ImgAssist becomes a robust tool, providing physicians with real-time visualization and assessment of surgical margins. This capability significantly enhances patient surgical outcomes and diminishes the necessity for subsequent operations. The company further provides a specialized image library and disposable specimen containers, catering to hospitals and cancer treatment facilities. Established in 2013, Perimeter Medical Imaging AI, Inc. operates from its headquarters in Toronto, Canada.
- Sector
- General
- Industry
- Medical - Devices
- CEO
- Adrian Mendes
- Employees
- 36
- Website
- www.perimetermed.com
- Address
- 555 Richmond Street West, Toronto, ON, M5V 3B1, CA
Perimeter Medical Imaging AI (PYNKF) Earnings & Revenues
PYNKF Earnings Call
Earnings Call SentimentPositive
The call presented a largely positive commercial and operational inflection: meaningful sequential recurring revenue growth (+31% QoQ), significant cost reductions (OpEx down 28%), improvement in net loss (down 33%), reduced operating cash burn (down 23%), FDA PMA approval for the B-Series, two initial commercial B-Series placements now performing procedures, and a CMS filing in process. Counterbalancing this are the small absolute revenue base, ongoing losses and limited cash balance (~$6.4M), early-stage commercial scale (only two B-Series in the field), and timing uncertainty driven by evolving hospital AI/IT review processes and fluid pipeline visibility. Overall, the highlights outweigh the lowlights given the regulatory milestone, initial commercial traction and improving financial trends, but execution and cash management remain critical near-term risks.
View all PYNKF earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 2 | 5 | 15 |
| Technical Analysis | 2 | 5 | 3 |
| Moving Averages | 0 | 0 | 12 |
